Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.

Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.

For the treatment of patients with multiple sclerosis there are no regenerative approaches to enhance remyelination. Mesenchymal stem cells (MSC) have been proposed to exert such regenerative functions. Intravenous administration of human MSC reduced the clinical severity of experimental autoimmune...

Full description

Bibliographic Details
Main Authors:	Jasmin Nessler, Karelle Bénardais, Viktoria Gudi, Andrea Hoffmann, Laura Salinas Tejedor, Stefanie Janßen, Chittappen Kandiyil Prajeeth, Wolfgang Baumgärtner, Annemieke Kavelaars, Cobi J Heijnen, Cindy van Velthoven, Florian Hansmann, Thomas Skripuletz, Martin Stangel
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3724887?pdf=render

Similar Items

Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone Model
by: Stefan Gingele, et al.
Published: (2020-04-01)

Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination
by: Viktoria Gudi, et al.
Published: (2021-11-01)

Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
by: Viktoria eGudi, et al.
Published: (2014-03-01)

Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse.
by: Darius Moharregh-Khiabani, et al.
Published: (2010-01-01)

Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis
by: Laura Salinas Tejedor, et al.
Published: (2016-01-01)

Fumaric Acids Do Not Directly Influence Gene Expression of Neuroprotective Factors in Highly Purified Rodent Astrocytes
by: Kaweh Pars, et al.
Published: (2019-09-01)

Strain differences in cuprizone induced demyelination
by: Qili Yu, et al.
Published: (2017-11-01)

Oligodendroglial primary cilium heterogeneity during development and demyelination/remyelination
by: Giada Delfino, et al.
Published: (2022-11-01)

Ferroptosis: copper-iron connection in cuprizone-induced demyelination
by: Priya Jhelum, et al.
Published: (2022-01-01)

Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination
by: Martin Zirngibl, et al.
Published: (2022-05-01)

Regulation of neuroinflammatory properties of glial cells by T cell effector molecules
by: Chittappen K Prajeeth, et al.
Published: (2018-01-01)

Cuprizone-induced Demyelination in Mouse Brain is not due to Depletion of Copper
by: Megan L. Morgan, et al.
Published: (2022-09-01)

Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model
by: Stefan A. Berghoff, et al.
Published: (2017-12-01)

Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model.
by: Ian Tagge, et al.
Published: (2016-01-01)

Cuprizone feed formulation influences the extent of demyelinating disease pathology
by: Lillian M. Toomey, et al.
Published: (2021-11-01)

Clozapine administration enhanced functional recovery after cuprizone demyelination.
by: Nikki Templeton, et al.
Published: (2019-01-01)

Age Influences Microglial Activation After Cuprizone-Induced Demyelination
by: Barbara Klein, et al.
Published: (2018-09-01)

Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice
by: Andre Michael Mueller, et al.
Published: (2013-10-01)

GAS6 enhances repair following cuprizone-induced demyelination.
by: Vladislav Tsiperson, et al.
Published: (2010-12-01)

Mitochondrial transfer from mesenchymal stem cells to neural stem cells protects against the neurotoxic effects of cisplatin
by: Nabila Boukelmoune, et al.
Published: (2018-12-01)

Cuprizone demyelination induces a unique inflammatory response in the subventricular zone.
by: Hillis, J, et al.
Published: (2016)

Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice
by: Kelly F. Paton, et al.
Published: (2022-12-01)

Immunofluorescence assay for demyelination, remyelination, and proliferation in an acute cuprizone mouse model
by: Elizabeth D. Clawson, et al.
Published: (2023-03-01)

Effect of Sox10 on remyelination of the hippocampus in cuprizone‐induced demyelinated mice
by: Yu Shao, et al.
Published: (2020-06-01)

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model.
by: Stig Wergeland, et al.
Published: (2011-01-01)

Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming.
by: Viktoria Gudi, et al.
Published: (2011-01-01)

Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice
by: Lucas Wilken, et al.
Published: (2023-03-01)

Microglia/macrophage polarization regulates spontaneous remyelination in intermittent cuprizone model of demyelination
by: Davood Zarini, et al.
Published: (2024-03-01)

Exosome-specific loading Sox10 for the treatment of Cuprizone-induced demyelinating model
by: Jin He, et al.
Published: (2024-02-01)

Progesterone Enhanced Remyelination in the Mouse Corpus Callosum After Cuprizone Induced Demyelination
by: Iraj Ragerdi Kashani, et al.
Published: (2015-11-01)

Anti-LINGO -1 improved remyelination and neurobehavioral deficit in cuprizone-induced demyelination
by: Khadijeh Moradbeygi, et al.
Published: (2021-07-01)

Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
by: Sveinung Fjær, et al.
Published: (2013-01-01)

Altered functioning of the glucocorticoid receptor pathway is a vulnerability factor for development of PTSD symptomatology in response to military deployment to Afghanistan
by: Mirjam van Zuiden, et al.
Published: (2012-09-01)

Biological vulnerability factors for the development of PTSD, depressive, and fatigue symptoms in response to military deployment are condition specific
by: Mirjam van Zuiden, et al.
Published: (2012-09-01)

In Vivo Measurement of Neurochemical Abnormalities in the Hippocampus in a Rat Model of Cuprizone-Induced Demyelination
by: Do-Wan Lee, et al.
Published: (2020-12-01)

Localized Increased Permeability of Blood–Brain Barrier for Antibody Conjugates in the Cuprizone Model of Demyelination
by: Tatiana Abakumova, et al.
Published: (2023-08-01)

Effects of Venlafaxine, Risperidone and Febuxostat on Cuprizone-Induced Demyelination, Behavioral Deficits and Oxidative Stress
by: Dragos Paul Mihai, et al.
Published: (2021-07-01)

Microglial depletion exacerbates axonal damage and motor dysfunction in mice with cuprizone-induced demyelination
by: Shinji Yamamoto, et al.
Published: (2023-11-01)

Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination
by: Tanja Hochstrasser, et al.
Published: (2019-09-01)

Correction: Deep Gray Matter Demyelination Detected by Magnetization Transfer Ratio in the Cuprizone Model
Published: (2014-01-01)